Orion Market Research Pvt. Ltd. info@omrglobal.com +91 780-304-0404
Help Center
Careers
Contact

Substance Abuse Treatment Market

Substance Abuse Treatment Market Size, Share & Trends Analysis Report, By Treatment Type (Detoxification (Detox), Behavioral Therapy, Medication-Assisted Treatment (MAT), Counselling & Support Programs), By Drug Class (Opioid Antagonists, Partial Opioid Agonists, Full Agonists, Alcohol Dependence Medications, Smoking Cessation Products, Others), By Substance Type (Alcohol Dependence, Opioid Addiction, Tobacco/Nicotine Addiction, Cannabis Use Disorder, Stimulant Addiction, Others), Forecast Period (2026-2035)

Published: Jul 2026 | Report Code: OMR2022156 | Category : Pharmaceuticals | Delivery Format: /

Industry Overview

Substance abuse treatment market was valued at $16.03 billion in 2025 and is projected to reach $38.86 billion by 2035, growing at a CAGR of 9.2% during 2026 to 2035. The market growth is primarily driven by the rising prevalence of substance use disorders, particularly opioid and alcohol dependence, alongside increasing awareness and access to treatment solutions.

According to the World Health Organization (WHO), over 35 million people globally suffer from drug use disorders, while harmful alcohol use contributes to approximately 3 million deaths annually. Additionally, data from the U.S. Food and Drug Administration (FDA) highlights increasing approvals for medication-assisted treatment (MAT), strengthening therapeutic options.

The market encompasses pharmaceutical treatments such as opioid antagonists, nicotine replacement therapies, and behavioral therapies. Key end-use industries include hospitals, rehabilitation centers, specialty clinics, and outpatient care facilities. Increasing government initiatives, insurance coverage expansion, and technological integration in therapy programs are further accelerating industry expansion.

Market Dynamics

Rising Global Burden of Substance Use Disorders Driving Market Growth

The increasing global burden of substance abuse is a key driver of the substance abuse treatment market. The WHO reports that alcohol consumption alone accounts for over 5% of the global disease burden, while opioid misuse continues to rise, particularly in North America. The OECD estimates that substance use disorders reduce life expectancy by up to 20 years in severe cases, increasing demand for effective treatment solutions.

Governments globally are implementing policies to expand access to treatment. For instance, the U.S. FDA has accelerated approvals for buprenorphine-based therapies, while European healthcare systems are expanding reimbursement coverage for addiction treatments. Pharmaceutical companies are also investing in long-acting formulations and combination therapies to improve patient compliance. Between 2025 and 2026, leading companies are focusing on expanding MAT portfolios, developing extended-release formulations, and strengthening distribution networks to meet growing demand.

High Treatment Costs and Social Stigma Limiting Market Expansion

Despite strong growth prospects, the market faces challenges related to high treatment costs and social stigma associated with substance abuse. According to the OECD, limited access to affordable healthcare services remains a major barrier in developing regions, where treatment penetration rates are significantly lower.

Supply chain constraints and regulatory complexities also impact market growth. Pharmaceutical companies must comply with stringent regulations imposed by authorities such as the FDA and the European Commission, increasing development and approval timelines. Additionally, the availability of low-cost generic drugs exerts pricing pressure on branded products. To address these challenges, companies are investing in cost-effective therapies, digital health integration, and public awareness campaigns. Governments are also increasing funding for addiction treatment programs to improve accessibility and reduce stigma.

Market Segmentation

  • Based on the treatment type, the market is segmented into detoxification (detox), behavioral therapy, medication-assisted treatment (MAT), and counseling & support programs.
  • Based on the drug class, the market is segmented into opioid antagonists, partial opioid agonists, full agonists, alcohol dependence medications, smoking cessation products, and others.
  • Based on the substance type, the market is segmented into alcohol dependence, opioid addiction, tobacco/nicotine addiction, cannabis use disorder, stimulant addiction, and others.

Medication-Assisted Treatment (MAT) Segment Leads the Market

Medication-assisted treatment (MAT) dominates the substance abuse treatment market due to its proven effectiveness in managing opioid and alcohol dependence. MAT combines pharmacological treatments such as buprenorphine, methadone, and naltrexone with behavioral therapies, improving patient outcomes and reducing relapse rates. The growing opioid crisis, particularly in North America, has significantly increased the adoption of MAT. Regulatory bodies such as the FDA have approved several extended-release formulations, enhancing treatment adherence. Between 2022 and 2026, pharmaceutical companies have focused on developing long-acting injectable therapies and expanding access through telemedicine platforms. The segment’s dominance is further supported by strong reimbursement policies and increasing government funding for opioid addiction treatment programs.

Smoking Cessation Products Segment to Record Strong Growth

The smoking cessation products segment is expected to witness the fastest growth during the forecast period due to increasing awareness of tobacco-related health risks and rising regulatory restrictions on tobacco consumption. According to the WHO, tobacco use is responsible for over 7 million deaths annually, prompting governments to implement stricter policies and promote cessation programs. Nicotine replacement therapies (NRTs), including patches, gums, and lozenges, are gaining widespread adoption due to their accessibility and effectiveness. Also, pharmaceutical companies are investing in innovative delivery systems and combination therapies to improve success rates. Additionally, digital health platforms and mobile applications are supporting smoking cessation programs, further driving segment growth.

Regional Outlook

The global substance abuse treatment market is geographically segmented into North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa and Latin America).

United States Leads the Market

The United States dominates the substance abuse treatment market due to the high prevalence of opioid addiction and strong healthcare infrastructure. According to the CDC, over 100,000 drug overdose deaths were recorded annually in recent years, highlighting the urgent need for effective treatment solutions. The U.S. government has implemented several initiatives, including expanded access to MAT and increased funding for addiction treatment programs. The presence of leading pharmaceutical companies and advanced research capabilities further supports market growth. Additionally, favorable reimbursement policies and insurance coverage enhance accessibility to treatment services.

India to Record Strong Growth

India is expected to witness significant growth in the substance abuse treatment market due to increasing awareness and government initiatives. According to the WHO, substance abuse prevalence is rising in urban and semi-urban areas, creating demand for treatment solutions. The Indian government is investing in healthcare infrastructure and expanding access to addiction treatment programs. Additionally, the presence of a strong pharmaceutical manufacturing base supports the production of cost-effective generic drugs. Increasing collaborations between the public and private sectors are further driving market expansion.

Market Player Outlook

The substance abuse treatment market is highly competitive, characterized by the presence of global pharmaceutical companies and regional players. Key companies are focusing on product innovation, strategic partnerships, and geographical expansion to strengthen their market position. The leading players, such as Johnson & Johnson (Kenvue/Nicorette), Indivior PLC, Haleon plc (Nicotinell/Nicorette), Alkermes plc, and Emergent BioSolutions Inc., dominate the market through strong product portfolios and extensive distribution networks. Companies are investing in research and development to introduce advanced therapies and improve treatment outcomes. Additionally, the increasing adoption of digital health solutions and telemedicine is reshaping the competitive landscape, enabling companies to expand their reach and enhance patient engagement.

Recent Developments

  • In April 2026, Emergent BioSolutions strengthened its position in the substance abuse treatment market through a strategic partnership with the British Columbia Provincial Health Services Authority to supply NARCAN Nasal Spray. This collaboration supports the expansion of the Take-Home Naloxone Program, improving access to life-saving overdose reversal treatments across communities.
  • In February 2025, Indivior PLC strengthened its position in the substance abuse treatment market through S. Food and Drug Administration approval of updated labeling for SUBLOCADE. The introduction of a rapid initiation protocol significantly reduces treatment start time from one week to one hour, improving patient access and retention. Additionally, expanded injection site options enhance treatment flexibility and adherence.

The Report Covers

  • Market value data analysis of 2025 and forecast to 2035.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global substance abuse treatment market. Based on the availability of data, information related to new products and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.
  1. Report Summary
  • Current Industry Analysis and Growth Potential Outlook
  • Global Substance Abuse Treatment Market Sales Analysis – Treatment Type | Drug Class | Substance Type ($ Million)
  • Substance Abuse Treatment Market Sales Performance of Top Countries

1.1 Research Methodology

  • Primary Research Approach
  • Secondary Research Approach

1.2 Market Snapshot

  1. Market Overview and Insights

2.1 Scope of the Study

2.2 Analyst Insight & Current Market Trends

2.2.1 Key Substance Abuse Treatment Market Trends

2.2.2 Market Recommendations

2.3 Porter's Five Forces Analysis for the Substance Abuse Treatment Market

2.3.1 Competitive Rivalry

2.3.2 Threat of New Entrants

2.3.3 Bargaining Power of Suppliers

2.3.4 Bargaining Power of Buyers

2.3.5 Threat of Substitutes

  1. Market Determinants

3.1 Market Drivers

3.1.1 Drivers For Global Substance Abuse Treatment Market: Impact Analysis

3.2 Market Pain Points and Challenges

3.2.1 Restraints For Global Substance Abuse Treatment Market: Impact Analysis

3.3 Market Opportunities

3.3.1 Opportunities For Global Substance Abuse Treatment Market: Impact Analysis

  1. Competitive Landscape

4.1 Competitive Dashboard – Substance Abuse Treatment Market Revenue and Share by Manufacturers

  • Substance Abuse Treatment Product Comparison Analysis
  • Top Market Player Ranking Matrix

4.2 Key Company Analysis

4.2.1 Johnson & Johnson (Kenvue/Nicorette)

4.2.1.1 Overview

4.2.1.2 Product Portfolio

4.2.1.3 Financial Analysis

4.2.1.4 SWOT Analysis

4.2.1.5 Business Strategy

4.2.2 Indivior PLC

4.2.2.1 Overview

4.2.2.2 Product Portfolio

4.2.2.3 Financial Analysis

4.2.2.4 SWOT Analysis

4.2.2.5 Business Strategy

4.2.3 Haleon plc (Nicotinell/Nicorette)

4.2.3.1 Overview

4.2.3.2 Product Portfolio

4.2.3.3 Financial Analysis

4.2.3.4 SWOT Analysis

4.2.3.5 Business Strategy

4.2.4 Alkermes plc

4.2.4.1 Overview

4.2.4.2 Product Portfolio

4.2.4.3 Financial Analysis

4.2.4.4 SWOT Analysis

4.2.4.5 Business Strategy

4.2.5 Emergent BioSolutions Inc.

4.2.5.1 Overview

4.2.5.2 Product Portfolio

4.2.5.3 Financial Analysis

4.2.5.4 SWOT Analysis

4.2.5.5 Business Strategy

4.3 Top Winning Strategies by Market Players

4.3.1 Merger and Acquisition

4.3.2 Product Launch

4.3.3 Partnership And Collaboration

  1. Global Substance Abuse Treatment Market Sales Analysis by Treatment Type ($ Million)

5.1 Detoxification (Detox)

5.2 Behavioral Therapy

5.3 Medication-Assisted Treatment (MAT)

5.4 Counseling & Support Programs

  1. Global Substance Abuse Treatment Market Sales Analysis by Drug Class ($ Million)

6.1 Opioid Antagonists

6.2 Partial Opioid Agonists

6.3 Full Agonists

6.4 Alcohol Dependence Medications

6.5 Smoking Cessation Products

6.6 Others

  1. Global Substance Abuse Treatment Market Sales Analysis by Substance Type ($ Million)

7.1 Alcohol Dependence

7.2 Opioid Addiction

7.3 Tobacco/Nicotine Addiction

7.4 Cannabis Use Disorder

7.5 Stimulant Addiction

7.6 Others

  1. Regional Analysis

8.1 North American Substance Abuse Treatment Market Sales Analysis – Treatment Type | Drug Class | Substance Type | Country ($ Million)

8.1.1 United States

8.1.2 Canada

8.2 European Substance Abuse Treatment Market Sales Analysis – Treatment Type | Drug Class | Substance Type | Country ($ Million)

8.2.1 UK

8.2.2 Germany

8.2.3 Italy

8.2.4 Spain

8.2.5 France

8.2.6 Russia

8.2.7 Rest of Europe

8.3 Asia-Pacific Substance Abuse Treatment Market Sales Analysis – Treatment Type | Drug Class | Substance Type | Country ($ Million)

8.3.1 China

8.3.2 Japan

8.3.3 South Korea

8.3.4 India

8.3.5 Australia & New Zealand

8.3.6 ASEAN Countries

8.3.7 Rest of Asia-Pacific

8.4 Rest of the World Substance Abuse Treatment Market Sales Analysis – Treatment Type | Drug Class | Substance Type | Country ($ Million)

8.4.1 Latin America

8.4.2 Middle East and Africa

  1. Company Profiles

9.1 Alkermes plc

9.1.1 Quick Facts

9.1.2 Company Overview

9.1.3 Product Portfolio

9.1.4 Business Strategies

9.2 Amneal Pharmaceuticals, Inc.

9.2.1 Quick Facts

9.2.2 Company Overview

9.2.3 Product Portfolio

9.2.4 Business Strategies

9.3 Apotex Inc.

9.3.1 Quick Facts

9.3.2 Company Overview

9.3.3 Product Portfolio

9.3.4 Business Strategies

9.4 Asubio Pharma (Daiichi Sankyo)

9.4.1 Quick Facts

9.4.2 Company Overview

9.4.3 Product Portfolio

9.4.4 Business Strategies

9.5 BioCorRx, Inc.

9.5.1 Quick Facts

9.5.2 Company Overview

9.5.3 Product Portfolio

9.5.4 Business Strategies

9.6 Camurus AB

9.6.1 Quick Facts

9.6.2 Company Overview

9.6.3 Product Portfolio

9.6.4 Business Strategies

9.7 Cipla Ltd.

9.7.1 Quick Facts

9.7.2 Company Overview

9.7.3 Product Portfolio

9.7.4 Business Strategies

9.8 Dr. Reddy's Laboratories Ltd.

9.8.1 Quick Facts

9.8.2 Company Overview

9.8.3 Product Portfolio

9.8.4 Business Strategies

9.9 Emergent BioSolutions Inc.

9.9.1 Quick Facts

9.9.2 Company Overview

9.9.3 Product Portfolio

9.9.4 Business Strategies

9.10 Ethypharm

9.10.1 Quick Facts

9.10.2 Company Overview

9.10.3 Product Portfolio

9.10.4 Business Strategies

9.11 Glenmark Pharmaceuticals Ltd.

9.11.1 Quick Facts

9.11.2 Company Overview

9.11.3 Product Portfolio

9.11.4 Business Strategies

9.12 Haleon plc (Nicotinell/Nicorette)

9.12.1 Quick Facts

9.12.2 Company Overview

9.12.3 Product Portfolio

9.12.4 Business Strategies

9.13 Hikma Pharmaceuticals PLC

9.13.1 Quick Facts

9.13.2 Company Overview

9.13.3 Product Portfolio

9.13.4 Business Strategies

9.14 Indivior PLC

9.14.1 Quick Facts

9.14.2 Company Overview

9.14.3 Product Portfolio

9.14.4 Business Strategies

9.15 Johnson & Johnson (Kenvue/Nicorette)

9.15.1 Quick Facts

9.15.2 Company Overview

9.15.3 Product Portfolio

9.15.4 Business Strategies

9.16 Lupin Limited

9.16.1 Quick Facts

9.16.2 Company Overview

9.16.3 Product Portfolio

9.16.4 Business Strategies

9.17 Mallinckrodt Pharmaceuticals

9.17.1 Quick Facts

9.17.2 Company Overview

9.17.3 Product Portfolio

9.17.4 Business Strategies

9.18 Orexo AB

9.18.1 Quick Facts

9.18.2 Company Overview

9.18.3 Product Portfolio

9.18.4 Business Strategies

9.19 Rusan Pharma Ltd.

9.19.1 Quick Facts

9.19.2 Company Overview

9.19.3 Product Portfolio

9.19.4 Business Strategies

9.20 Sandoz Group AG

9.20.1 Quick Facts

9.20.2 Company Overview

9.20.3 Product Portfolio

9.20.4 Business Strategies

9.21 Sun Pharmaceutical Industries Ltd.

9.21.1 Quick Facts

9.21.2 Company Overview

9.21.3 Product Portfolio

9.21.4 Business Strategies

9.22 Teva Pharmaceutical Industries Ltd.

9.22.1 Quick Facts

9.22.2 Company Overview

9.22.3 Product Portfolio

9.22.4 Business Strategies

9.23 Titan Pharmaceuticals, Inc.

9.23.1 Quick Facts

9.23.2 Company Overview

9.23.3 Product Portfolio

9.23.4 Business Strategies

9.24 Viatris Inc.

9.24.1 Quick Facts

9.24.2 Company Overview

9.24.3 Product Portfolio

9.24.4 Business Strategies

9.25 Zydus Lifesciences Ltd.

9.25.1 Quick Facts

9.25.2 Company Overview

9.25.3 Product Portfolio

9.25.4 Business Strategies

1. Global Substance Abuse Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)

2. Global Detoxification (Detox) Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

3. Global Behavioral Therapy Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

4. Global Medication-Assisted Treatment (MAT) Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

5. Global Counseling & Support Programs Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

6. Global Substance Abuse Treatment Market Research and Analysis by Drug Class, 2025–2035 ($ Million)

7. Global Opioid Antagonists Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

8. Global Partial Opioid Agonists Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

9. Global Full Agonists Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

10. Global Alcohol Dependence Medications Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

11. Global Smoking Cessation Products Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

12. Global Others Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

13. Global Substance Abuse Treatment Market Research and Analysis by Substance Type, 2025–2035 ($ Million)

14. Global Alcohol Dependence Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

15. Global Opioid Addiction Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

16. Global Tobacco/Nicotine Addiction Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

17. Global Cannabis Use Disorder Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

18. Global Stimulant Addiction Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

19. Global Others Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

20. Global Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

21. North America Substance Abuse Treatment Market Research and Analysis by Country, 2025–2035 ($ Million)

22. North America Substance Abuse Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)

23. North America Substance Abuse Treatment Market Research and Analysis by Drug Class, 2025–2035 ($ Million)

24. North America Substance Abuse Treatment Market Research and Analysis by Substance Type, 2025–2035 ($ Million)

25. Europe Substance Abuse Treatment Market Research and Analysis by Country, 2025–2035 ($ Million)

26. Europe Substance Abuse Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)

27. Europe Substance Abuse Treatment Market Research and Analysis by Drug Class, 2025–2035 ($ Million)

28. Europe Substance Abuse Treatment Market Research and Analysis by Substance Type, 2025–2035 ($ Million)

29. Asia-Pacific Substance Abuse Treatment Market Research and Analysis by Country, 2025–2035 ($ Million)

30. Asia-Pacific Substance Abuse Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)

31. Asia-Pacific Substance Abuse Treatment Market Research and Analysis by Drug Class, 2025–2035 ($ Million)

32. Asia-Pacific Substance Abuse Treatment Market Research and Analysis by Substance Type, 2025–2035 ($ Million)

33. Rest of the World Substance Abuse Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)

34. Rest of the World Substance Abuse Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)

35. Rest of the World Substance Abuse Treatment Market Research and Analysis by Drug Class, 2025–2035 ($ Million)

36. Rest of the World Substance Abuse Treatment Market Research and Analysis by Substance Type, 2025–2035 ($ Million)

1. Global Substance Abuse Treatment Market Share by Treatment Type, 2025 Vs 2035 (%)

2. Global Detoxification (Detox) Substance Abuse Treatment Market Research and Analysis by Region, 2025 vs 2035 (%)

3. Global Behavioral Therapy Substance Abuse Treatment Market Research and Analysis by Region, 2025 Vs 2035 (%)

4. Global Medication-Assisted Treatment (MAT) Substance Abuse Treatment Market Research and Analysis by Region, 2025 vs 2035 (%)

5. Global Counseling & Support Programs Substance Abuse Treatment Market Research and Analysis by Region, 2025 Vs 2035 (%)

6. Global Substance Abuse Treatment Market Share by Drug Class, 2025 Vs 2035 (%)

7. Global Opioid Antagonists Substance Abuse Treatment Market Research and Analysis by Region, 2025 Vs 2035 (%)

8. Global Partial Opioid Agonists Substance Abuse Treatment Market Research and Analysis by Region, 2025 Vs 2035 (%)

9. Global Full Agonists Substance Abuse Treatment Market Research and Analysis by Region, 2025 Vs 2035 (%)

10. Global Alcohol Dependence Medications Substance Abuse Treatment Market Research and Analysis by Region, 2025 vs 2035 (%)

11. Global Smoking Cessation Products Substance Abuse Treatment Market Research and Analysis by Region, 2025 Vs 2035 (%)

12. Global Others Substance Abuse Treatment Market Research and Analysis by Region, 2025 Vs 2035 (%)

13. Global Substance Abuse Treatment Market Share by Substance Type, 2025 Vs 2035 (%)

14. Global Alcohol Dependence Substance Abuse Treatment Market Research and Analysis by Region, 2025 Vs 2035 (%)

15. Global Opioid Addiction Substance Abuse Treatment Market Research and Analysis by Region, 2025 Vs 2035 (%)

16. Global Tobacco/Nicotine Addiction Substance Abuse Treatment Market Research and Analysis by Region, 2025 Vs 2035 (%)

17. Global Cannabis Use Disorder Substance Abuse Treatment Market Research and Analysis by Region, 2025 Vs 2035 (%)

18. Global Stimulant Addiction Substance Abuse Treatment Market Research and Analysis by Region, 2025 Vs 2035 (%)

19. Global Others Substance Abuse Treatment Market Research and Analysis by Region, 2025 Vs 2035 (%)

20. Global Substance Abuse Treatment Market Share by Region, 2025 Vs 2035 (%)

21. United States Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

22. Canada Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

23. UK Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

24. France Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

25. Germany Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

26. Italy Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

27. Spain Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

28. Russia Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

29. India Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

30. China Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

31. Japan Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

32. South Korea Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

33. Australia & New Zealand Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

34. ASEAN Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

35. Rest of Asia-Pacific Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

36. Latin America Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

37. Middle East & Africa Substance Abuse Treatment Market Size, 2025-2035 ($ Million)

Choose License Type
    On Discount
Enterprise Custom
  • Printable version
  • No restriction to number of users within the company
CONTACT SALES

100%
Secured Payment

Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports

FAQS

The Substance Abuse Treatment market was valued at $16.03 billion in 2025 and is projected to reach $38.86 billion by 2035.
The market is expected to grow at a CAGR of 9.2% during the forecast period 2026–2035.
Medication-Assisted Treatment (MAT) dominates the market due to its high effectiveness in treating opioid and alcohol dependence.
North America, particularly the United States, leads the market due to the high prevalence of substance abuse and strong healthcare infrastructure.
Key trends include increasing adoption of MAT, growth in smoking cessation products, and integration of digital health technologies in treatment programs.